Description
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
TAT:
Specimen Type:
Genomics Panel Test
Other Tests
-
249%
Endopredict
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM 500 gene panel (Basic)
Identification of therapeutically relevant gene mutations for Cancer
OncQuer TM 500 gene panel (Basic)
Identification of therapeutically relevant gene mutations for Cancer
-
264%
OncQuer(TM) CML panel
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer(TM) CML panel
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.